Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL-2 antibody

This Rat Monoclonal antibody specifically detects IL-2 in ELISA and Inhibition. It exhibits reactivity toward Human and has been mentioned in 3+ publications.
Catalog No. ABIN2689751

Quick Overview for IL-2 antibody (ABIN2689751)

Target

See all IL-2 (IL2) Antibodies
IL-2 (IL2) (Interleukin 2 (IL2))

Reactivity

  • 162
  • 92
  • 51
  • 18
  • 16
  • 11
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 141
  • 118
  • 58
  • 10
  • 4
  • 4
  • 2
Rat

Clonality

  • 180
  • 154
  • 1
Monoclonal

Conjugate

  • 203
  • 42
  • 26
  • 20
  • 18
  • 9
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IL-2 antibody is un-conjugated

Application

  • 224
  • 132
  • 122
  • 93
  • 89
  • 68
  • 24
  • 21
  • 14
  • 14
  • 14
  • 13
  • 13
  • 11
  • 10
  • 9
  • 6
  • 6
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Blocking Antibody (Inhibition)

Clone

MQ1
  • Brand

    BD Pharmingen™

    Characteristics

    The MQ1-17H12 antibody reacts with human interleukin-2 (IL-2). The immunogen used to generate the MQ1-17H12 hybridoma was recombinant human IL-2. Unconjugated or purified forms of this antibody have been reported to be neutralizing for human IL-2 bioactivity. Expression of IL-2 by stimulated CD3+ human PBMC. Human PBMCs were stimulated for 6 hours with PMA (50 ng/mL final concentration, Sigma, Cat. #P-8139) and calcium ionophore A23187 (500-100 ng/mL final concentration, Sigma, Cat. #C-9275) in the presence of BD GolgiStop™ (2 μM final concentration, Cat. No. 554724). The PBMCs were stained with PE-Cy™5-anti-CD3 (PE-Cy™5-UCHT1, Cat. No. 555334), fixed, permeabilized, and then stained with 0.25 μg of FITC-rat anti-human IL-2 antibody (FITC-MQ1-17H12, Cat. No. 554565) using Pharmingen's staining protocol (left panel). To demonstrate specificity of staining, the binding of FITC-MQ1-17H12 was blocked by the preincubation of the fluorochrome - conjugated antibody with recombinant human IL-2 (10 ng/mL final concentration, Cat. No. 554603, middle panel), and by preincubation of the fixed/permeabilized cells with unlabeled MQ1-17H12 antibody (5.0 μg, Cat. No. 554563, right panel) prior to staining with the FITC-MQ1-17H12 antibody. The quadrant markers for the bivariate dot plots were set based on the autofluorescence control, and verified with the recombinant cytokine blocking (middle panel) and unlabeled antibody blocking (right panel) specificity controls.

    BD Pharmingen™ Purified Rat Anti-Human IL-2 - Purified - Clone MQ1-17H12 - Isotype Rat IgG2a, κ - Reactivity Hu - 0.1 mg

    Purification

    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

    Immunogen

    Human IL-2 Recombinant Protein

    Isotype

    IgG2a kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    Aqueous buffered solution containing ≤0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store undiluted at 4°C.
  • Prussin, Metcalfe: "Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies." in: Journal of immunological methods, Vol. 188, Issue 1, pp. 117-28, (1996) (PubMed).

    Andersson, Abrams, Björk, Funa, Litton, Agren, Andersson: "Concomitant in vivo production of 19 different cytokines in human tonsils." in: Immunology, Vol. 83, Issue 1, pp. 16-24, (1995) (PubMed).

    Fernandez, Andersson, Andersson, Troye-Blomberg: "Cytokine synthesis analyzed at the single-cell level before and after revaccination with tetanus toxoid." in: European journal of immunology, Vol. 24, Issue 8, pp. 1808-15, (1994) (PubMed).

  • Target

    IL-2 (IL2) (Interleukin 2 (IL2))

    Alternative Name

    IL-2

    Pathways

    JAK-STAT Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
You are here:
Chat with us!